Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

An innovative research project with the potential for transforming our understanding and treatment of the long-term cardiovascular consequences of diabetes will soon get underway at Oxford University thanks to support from the Kusuma Trust.

Healthcare professional taking a blood glucose reading from a patient © © Shutterstock/Dragana Gordic

Diabetes is a huge and growing global problem. Around 476 million people are thought to live with the disease worldwide, with those who do twice as likely to die from a heart attack as a non-diabetic person. Understanding how diabetes distorts and disrupts the immune system and how that, in turn, drives coronary artery and vascular disease, leading to heart attack and stroke, is of great importance.

A gift of £149,990 from the Kusuma Trust will enable researchers in the Radcliffe Department of Medicine to build on earlier work exploring this link. In 2021 the Choudhury Lab discovered that diabetes fundamentally reprogrammes the immune system, thereby exacerbating cardiovascular disease and its complications. Their findings addressed the paradox of why treating high glucose in patients with diabetes does not reduce the risk of heart attack.

With the support of the Trust, the Choudhury Lab will now explore how to use these findings for patient benefit. The work, led by Professor Robin Choudhury and undertaken by Dr Kate Robinson, will delve deeper into how parts of the immune system get jammed ‘on’ in diabetes.

Read the full story on the Oxford Giving website

Similar stories

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Oxford medical student takes AI safety message to the Palace of Versailles

Oxford medical student Julian Shellard has presented at an international workshop on the future of Artificial Intelligence (AI) at the Palace of Versailles in Paris, highlighting the important role medical students can play in global conversations on shaping the future of science and medicine.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group at the MRC Weatherall Institute of Molecular Medicine, have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Dunn School publishes new children’s book to mark centenary

The collaboration with Oxford University Press brings the story of the development of Penicillin to a new audience